Smart Devices–Based Longitudinal Assessment of Patterns of Insomnia (SLEEPI): Protocol for Large-Scale, Digital, Longitudinal, and Decentralized Clinical Trials
5 affiliations
- 1Inserm, F-75019, NeuroDiderot, SleepCmd, Université Paris Cité, Bingen, 48 boulevard Sérurier, Paris, Île-de-France, 75019, France
- 2Department of Computer Science, Reykjavík University, Reykjavik, Iceland
- 3Withings (France), 2 rue Maurice Hartmann, Issy-les-Moulineaux, Île-de-France, 92130, France, 33 646668445
- 4Hopital Bichat - Claude Bernard, F-75018, Département de psychiatrie et d’addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Paris, France
- 5GHU Paris - Psychiatry & Neurosciences, Centre ChronoS, Paris, France
Abstract
Background: Personalized medicine requires an understanding of health conditions in real-world settings, but traditional clinical tools are often poorly suited for longitudinal tracking due to logistical hurdles, high participant burden, and data quality issues. While consumer wearables offer a scalable alternative, decentralized clinical trials introduce new challenges in patient recruitment, sustained engagement, and data management. Insomnia serves as a suitable use case for this protocol due to its global prevalence, frequent underdiagnosis, and the well-documented discrepancy between subjective patient reports and objective physiological metrics.
Objective: We present a research protocol for large-scale decentralized clinical trials and report its recruitment performance, applied to a longitudinal study on insomnia, called the SLEEPI (Smart Devices–Based Longitudinal Assessment of Patterns of Insomnia) study, using an established base of commercial devices with limited additional manual intervention. This study aims to develop a machine learning model classifying subjective insomnia presence at the participant level against DSM-5-TR (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision) criteria.
Methods: Two data streams are collected: subjective, clinically anchored patient reports and objective physiological metrics (eg, heart and respiratory rates) captured via unobtrusive wearable and nearable sensors. This study is executed through a digital protocol designed to conduct a large-scale, longitudinal clinical trial. This protocol replaces the manual interventions of site-based studies with digital tools that manage the full participation process. We detail this protocol from initial recruitment through engagement, adherence, study monitoring, and data management to study completion or withdrawal. The data collected are intended to train and evaluate a machine learning model for subjective insomnia classification. The recruitment objectives were determined by using simulations to determine the minimal sample size for that purpose and by applying a prospective attrition model to calculate the initial contact volume needed to reach that targeted sample.
Results: This protocol enables the continuous monitoring of over 10,000 individuals for 26 weeks. Enrollment metrics exceeded projections: initial survey response rates reached 16% (vs 10% projected), the consent rate was 96% (vs 77% projected), and the final inclusion rate was 90% (vs 81% projected). Recruitment opened in February 2025, and the initial wave closed 6 weeks later with 10,823 individuals included. Data collection is projected to end in June 2027. Preliminary analyses have been conducted, and the first results are expected in the summer of 2027.
Conclusions: This protocol uses preexisting user bases of connected devices to conduct the trial with limited additional manual intervention. Beyond insomnia, the protocol is intended as a model for generating large-scale, real-world clinical datasets, presenting new opportunities for research in other complex areas such as immunology, mental health, and cardiovascular diseases.
Related
- Real-world device survival, revision burden and observed pain patterns after epidural spinal cord stimulation for neuropathic pain in adults with spinal cord injury: protocol for a longitudinal observational cohort study using routine clinical data
- Risk assessment and prediction of myopia among school-age children in South China: protocol for a longitudinal follow-up study
- Intensive longitudinal assessment of stress and stress-related concepts across a weight loss program: Protocol for a longitudinal ecological momentary assessment study
- Sample size determination for randomized decentralized clinical trials with longitudinal outcomes
- Longitudinal multi-night home-based sleep assessment before and after metabolic bariatric surgery: protocol for the SLEEP-BAM cohort.
BibTeX
@article{stefanos2026smart,
title = {{Smart Devices–Based Longitudinal Assessment of Patterns of Insomnia (SLEEPI): Protocol for Large-Scale, Digital, Longitudinal, and Decentralized Clinical Trials}},
author = {Marie-Ange Stefanos and Martin de Gourcuff and Guillaume de Laboulaye and David Campo and Pierre Alexis Geoffroy and Anna Sigridur Islind},
journal = {JMIR Research Protocols},
year = {2026},
month = nov,
doi = {10.2196/92341},
url = {https://doi.org/10.2196/92341},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Smart Devices–Based Longitudinal Assessment of Patterns of Insomnia (SLEEPI): Protocol for Large-Scale, Digital, Longitudinal, and Decentralized Clinical Trials
AU - Marie-Ange Stefanos
AU - Martin de Gourcuff
AU - Guillaume de Laboulaye
AU - David Campo
AU - Pierre Alexis Geoffroy
AU - Anna Sigridur Islind
PY - 2026
DA - 2026/11/02
JO - JMIR Research Protocols
DO - 10.2196/92341
UR - https://doi.org/10.2196/92341
AB - Background: Personalized medicine requires an understanding of health conditions in real-world settings, but traditional clinical tools are often poorly suited for longitudinal tracking due to logistical hurdles, high participant burden, and data quality issues. While consumer wearables offer a scalable alternative, decentralized clinical trials introduce new challenges in patient recruitment, sustained engagement, and data management. Insomnia serves as a suitable use case for this protocol due to its global prevalence, frequent underdiagnosis, and the well-documented discrepancy between subjective patient reports and objective physiological metrics. Objective: We present a research protocol for large-scale decentralized clinical trials and report its recruitment performance, applied to a longitudinal study on insomnia, called the SLEEPI (Smart Devices–Based Longitudinal Assessment of Patterns of Insomnia) study, using an established base of commercial devices with limited additional manual intervention. This study aims to develop a machine learning model classifying subjective insomnia presence at the participant level against DSM-5-TR (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision) criteria. Methods: Two data streams are collected: subjective, clinically anchored patient reports and objective physiological metrics (eg, heart and respiratory rates) captured via unobtrusive wearable and nearable sensors. This study is executed through a digital protocol designed to conduct a large-scale, longitudinal clinical trial. This protocol replaces the manual interventions of site-based studies with digital tools that manage the full participation process. We detail this protocol from initial recruitment through engagement, adherence, study monitoring, and data management to study completion or withdrawal. The data collected are intended to train and evaluate a machine learning model for subjective insomnia classification. The recruitment objectives were determined by using simulations to determine the minimal sample size for that purpose and by applying a prospective attrition model to calculate the initial contact volume needed to reach that targeted sample. Results: This protocol enables the continuous monitoring of over 10,000 individuals for 26 weeks. Enrollment metrics exceeded projections: initial survey response rates reached 16% (vs 10% projected), the consent rate was 96% (vs 77% projected), and the final inclusion rate was 90% (vs 81% projected). Recruitment opened in February 2025, and the initial wave closed 6 weeks later with 10,823 individuals included. Data collection is projected to end in June 2027. Preliminary analyses have been conducted, and the first results are expected in the summer of 2027. Conclusions: This protocol uses preexisting user bases of connected devices to conduct the trial with limited additional manual intervention. Beyond insomnia, the protocol is intended as a model for generating large-scale, real-world clinical datasets, presenting new opportunities for research in other complex areas such as immunology, mental health, and cardiovascular diseases.
SN - 1929-0748
ER -